Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide

Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3). To avoid urotoxicity of ifosfamide, mesna, a uroprotective drug, was additionally given in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Deutsche medizinische Wochenschrift 1983-05, Vol.108 (21), p.810
Hauptverfasser:	Matthiessen, W, Stempinski, E, Göbel, D, Thalmann, U
Format:	Artikel
Sprache:	ger
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adult Aged Carcinoma - drug therapy Carcinoma - pathology Carcinoma, Bronchogenic - drug therapy Carcinoma, Bronchogenic - pathology Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Cyclophosphamide - analogs & derivatives Doxorubicin - adverse effects Doxorubicin - therapeutic use Drug Therapy, Combination Female Humans Ifosfamide - adverse effects Ifosfamide - therapeutic use Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Middle Aged Neoplasm Metastasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!